Strattera approved to treat ADHD.
D000069445:Atomoxetine Hydrochloride; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D017277:Drug Approval; D006801:Humans; D011437:Propylamines / Q000627:therapeutic use*; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D011437:Propylamines; D011619:Psychotropic Drugs; D000069445:Atomoxetine Hydrochloride